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The organization of the mitochondrial electron transport chain
proteins into supercomplexes (SCs) is now undisputed; however,
their assembly process, or the role of differential expression
isoforms, remain to be determined. In Saccharomyces cerevisiae,
cytochrome c oxidase (CIV) forms SCs of varying stoichiometry
with cytochrome bc1 (CIII). Recent studies have revealed, in
normoxic growth conditions, an interface made exclusively by
Cox5A, the only yeast respiratory protein that exists as one of
two isoforms depending on oxygen levels. Here we present the
cryo-EM structures of the III2-IV1 and III2-IV2 SCs containing the
hypoxic isoform Cox5B solved at 3.4 and 2.8 Å, respectively. We
show that the change of isoform does not affect SC formation or
activity, and that SC stoichiometry is dictated by the level of CIII/
CIV biosynthesis. Comparison of the CIV5B- and CIV5A-containing
SC structures highlighted few differences, found mainly in the
region of Cox5. Additional density was revealed in all SCs, inde-
pendent of the CIV isoform, in a pocket formed by Cox1, Cox3,
Cox12, and Cox13, away from the CIII–CIV interface. In the CIV5B-
containing hypoxic SCs, this could be confidently assigned to the
hypoxia-induced gene 1 (Hig1) type 2 protein Rcf2. With con-
served residues in mammalian Hig1 proteins and Cox3/Cox12/
Cox13 orthologs, we propose that Hig1 type 2 proteins are stoi-
chiometric subunits of CIV, at least when within a III-IV SC.
bioenergetics | electron transport chain | cytochrome c oxidase | Hig1
proteins | respiratory supercomplexes
To live, we need a permanent supply of energy and most of thisis provided to our cells in the form of adenosine triphosphate
(ATP). ATP is continuously synthesized in our mitochondria by
the action of five large protein complexes, named complexes I-V
(CI-V), in a process called oxidative phosphorylation. CI-IV
reduce the oxygen we breathe using electrons provided by the
food we eat and store the energy of the reaction as a trans-
membrane proton motive force that drives ATP synthesis by CV
(1). Despite earlier assumptions that CI-V were randomly dis-
tributed within the inner mitochondrial membrane (IMM), it is
now widely accepted that they form higher-order structures
in vivo (2, 3). The arrangement of CV in rows of V-shaped di-
mers has been linked to membrane bending and cristae forma-
tion (4–6), and a functional role for CV tetramers has recently
been suggested (7). However, the roles of the supercomplexes
(SCs) formed by CI-IV, as well as their assembly process, remain
to be established (8–10).
Major complications in assigning functional roles to SCs are
the heterogeneity of SC populations that coexist in the IMM and
the inherent difficulty in separating SC assembly intermediates
from their mature forms. This is further complicated by the
presence of tissue-specific isoforms of the respiratory complexes,
which may only be assembled into SCs in specific conditions.
Several high-resolution structures of CI-containing mammalian
SCs obtained by single-particle cryogenic electron microscopy
(cryo-EM) are available. These include structures of “respirasomes”
formed by CI, III, and IV in varying stoichiometries (11–14) and I–
III2 SCs (11, 14). Overall, they reveal a conserved arrangement of
CI and CIII across species, including strong protein–protein inter-
actions. Slightly different orientations of CIII relative to CI within
the respirasome have been reported that have been linked to in-
stability of the SC during the purification procedure, although the
possibility of a subpopulation of respirasomes in which CI is in the
deactivated state could not be excluded (9, 14). However, when
present, CIV was found in very different positions, making it more
difficult to determine any conserved pattern of interaction. Similarly
in the bovine, porcine, and tight ovine respirasome structures, CIV
interacts with CIII via subunit COX7A (11, 12, 14, 15), albeit in very
different positions, whereas in the loose ovine and human struc-
tures, the same CIV subunit interacts with CI instead (11, 13).
The existence of homologous proteins for COX7A may pro-
vide a rationale for the different CIV orientation/COX7A in-
teractions observed. COX7A1 and COX7A2 are differentially
expressed isoforms, and a third is the SC assembly factor 1
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(SCAF1) incriminated in III-IV SC assembly/stability (16, 17).
Their coexistence in varying ratios in different tissue types might
have contributed to the difficulty in identifying specific isoforms
in most of the reported structures, with only COX7A2 assigned
with confidence in respirasomes purified from human epithelial
kidney cells (18), and the possibility that different COX7A iso-
forms assemble into different SCs cannot be excluded. To de-
termine whether the observed heterogeneity of SC structures are
artifacts of SC purification or cryo-EM sample preparation, or
whether physiologically relevant isoforms of the mammalian
respirasome mediate changes in SC stoichiometry/architecture,
new methods are needed that selectively isolate specific SC
isoforms and SC assembly intermediates.
Saccharomyces cerevisiae is an ideal system for investigating
mitochondrial respiratory protein organization. It lacks CI, but
its CII-V are remarkably similar to its mammalian counterparts
in terms of subunit composition, existence of isoforms and SC
association, and the genetic amenability of its nuclear and mi-
tochondrial DNA allows alterations to any part of the respiratory
proteins to comprehensively test hypotheses. The structures of
the mitochondrial III2-IV2 and III2-IV1 SCs formed in S. cer-
evisiae have recently been published (19, 20); however, the rea-
son for the existence of two different SCs remains to be
determined. The mild detergents used to purify the yeast SCs
allowed the first full structure determination of both CIII and
CIV at atomic resolution, including Qcr10 of CIII and Cox26 of
CIV, and their presence was also confirmed by mass spectrom-
etry (19). The EM maps revealed similar interactions between
CIII and CIV, irrespective of the III-IV stoichiometry, with an
interface formed exclusively by subunit Cox5A of CIV. Curi-
ously, Cox5 is the only subunit in yeast that exists as one of two
isoforms depending on oxygen levels (21), Cox5A or Cox5B,
expressed in normoxic or hypoxic conditions, respectively. De-
spite different CIV subunits interacting with CIII within the
mammalian respirasomes (COX7A) and the yeast III-IV SCs
(Cox5), in all structures the CIII–CIV interface is formed by a
CIV subunit with isoforms that have also been implicated in
modulation of CIV activity (22–24).
Along with the respiratory complexes that form the mito-
chondrial SCs, several proteins have been implicated to have
roles in SC assembly or stability; however, no SC structure has
been solved with an assembly factor/scaffold protein present, so
these roles remain undefined. In yeast, the proteins most closely
associated with SC assembly are the respiratory SC factors Rcf1-
3 (25–28). Mass spectrometry revealed the presence of both Rcf1
and Rcf2 in the purified III2-IV2 SC sample used for structure
determination, although no density for additional proteins could
be seen in the EM maps published (19).
In this study, we used three yeast variants that differentially
assemble CIV with its Cox5A or Cox5B isoform and investigated
the effect of CIV isoform exchange on SC formation, structure,
and activity. We found that the change of Cox5 isoform did not
affect III-IV SC formation or their overall CIII-CIV arrange-
ment, but that the III-IV SC stoichiometry was governed by the
varying CIV expression levels seen in the different strains used.
Atomic models of the different assemblies revealed few differ-
ences between them, although additional density was revealed in
all III-IV SCs, independent of the isoform. In the two SCs
containing CIV5B, this could be confidently assigned to the C-
terminal fragment of Rcf2, calling into question the proposed
role of Rcf2 as a late CIV assembly factor (26, 29, 30) and
suggesting that it is a stoichiometric subunit of CIV within the
III-IV SCs.
Results
Yeast Strains.When cultured in normoxic conditions, S. cerevisiae
wild-type (WT) mainly assembles CIV with the Cox5A isoform.
However, a small proportion of Cox5B is also expressed, leading
to a heterogeneous population of CIV and, as a result, a het-
erogeneous population of III-IV SCs. To avoid this and ensure
SC homogeneity, we used a series of S. cerevisiae mutant strains
that selectively express Cox5A or Cox5B (23). In Δcox5b, the
gene encoding the Cox5B protein was knocked out from the
nuclear genome so that it only assembled CIV with Cox5A
(CIV5A). Two mutant strains were used to produce CIV with
Cox5B (CIV5B). The first strain was a combination knockout of
Δcox5a Δrox1 (henceforth referred to as Δrox1) in which the
genes encoding Cox5A and Rox1, a repressor of COX5B ex-
pression, were knocked out, with the effect of elevating the ex-
pression level of Cox5B when cultured in normoxic conditions.
This resulted in assembly of slightly higher amounts of
CIV5B compared with a single Δcox5a knockout mutant, albeit
still at much lower levels than CIV5A in the WT (or Δcox5b)
strain. In the second mutant strain, cox5ab, both the COX5A and
COX5B genes were knocked out, and the sequence encoding
Cox5B was placed downstream of the COX5A promoter, leading
to the assembly of CIV5B at CIV5A WT levels, with no additional
change. All mutant strains carried an additional 6-histidine tag
on the C-terminal domain of Cox13 for facile CIV/SC purifica-
tion as described previously (31).
The III-IV SC Stoichiometry Is Governed by the Relative Amounts of
CIII and CIV within the Mitochondrial Membrane. The three yeast
variants were cultured under the same conditions and harvested
in the late exponential phase of growth, and mitochondrial
membranes were prepared as described in Materials and Meth-
ods. CIII and CIV were then quantitated in each preparation
from the specific absorption of their B- and A-type hemes, re-
spectively, in dithionite-reduced minus oxidized difference
spectra, recorded in the visible range (Fig. 1A). Very similar
difference spectra were recorded for all three mutant strains,
with only the ratio of CIII over that of CIV differing between
strains. The Δcox5b and cox5ab strains displayed a CIII:CIV ratio
in mitochondrial membranes of close to 3, whereas in Δrox1, this
ratio was estimated to be as high as 12. This is a consequence of
the low level of Cox5B in Δrox1 and the resulting low
CIV5B abundance in the membrane, with the amount of CIII
being constant across the three strains.
To assess whether this change in CIII:CIV ratio had an impact
on SC formation, the mitochondrial membranes from each strain
were solubilized with the mild detergent glyco-diosgenin (GDN),
and the migration profiles of the resulting respiratory assemblies
were observed using blue native (BN)-PAGE (Fig. 1B). III2-IV2
and III2-IV1 SCs were detected in both Δcox5b and cox5ab mi-
tochondrial membranes, with approximately equal contributions,
but only III2-IV1 SCs appeared to have formed in Δrox1. This
observation and the fact that Δrox1 contained only one-fourth of
the mature CIV contained in the two other strains suggest that
the protein stoichiometry of the III-IV SCs is governed by the
relative amounts of CIII and CIV within the mitochondrial
membrane, independent of whether CIV has assembled with the
Cox5A (Δcox5b) or Cox5B (cox5ab and Δrox1) isoform. It is
noteworthy that a significant amount of free III2 was detected in
Δrox1 mitochondrial membranes, whereas none could be seen in
the two other strains (Fig. 1B).
Selection of SCs Containing Fully Assembled CIV. The III-IV SCs
from all three mutant strains were then purified by metal affinity
chromatography, exploiting a 6-histidine tag on Cox13 of CIV, as
previously described for Δcox5b (19). In the case of Δcox5b and
cox5ab, the BN-PAGE migration profiles of the resulting chro-
matography eluates highlighted a change in the relative contri-
butions of the III2-IV2 and III2-IV1 forms of the SC from an
estimated 50:50 to 80:20 after metal affinity chromatography
(Fig. 1D). This shift in contribution most likely arises from the
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biased selection of the SCs with two copies of CIV, due to the
presence of two copies of the histidine-tagged subunit Cox13.
It has recently been proposed that CIII could serve as a
platform for the completion of CIV biogenesis (32). As Cox13 is
one of the last subunits (along with Cox12) to assemble into CIV
(33), it is interesting to speculate that the metal affinity chro-
matography step could have promoted the selection of SCs
containing mature forms of CIV (i.e., those CIVs that have at
least assembled Cox13) and thus maximized the homogeneity of
the SC populations.
Purified III-IV SCs Are Active but Do Not Differ in Their Catalytic
Activity. The III-IV5B SCs from Δrox1 and cox5ab were further
purified by gel filtration chromatography (SI Appendix, Fig. S1).
The final samples were active and reduced the molecular oxygen
in the presence of exogenous cytochrome c at a rate of 10.8 ± 1.4
e.s−1 for Δrox1 (n = 3) and 9.7 ± 0.2 e.s−1 for cox5ab (n = 3),
using decylubiquinol as a substrate. Compared with the rate of
10.3 ± 0.9 e.s−1 previously reported for the III2-IV
5A
2 Δcox5b SC
(19), this suggests similar activity of the three SCs tested, inde-
pendent of the presence of CIV5A or CIV5B or of the CIII:CIV
stoichiometry. All rates were expressed as turnover numbers
(TNs) relative to the concentration of the rate-limiting CIII.
The CIII–CIV Interface Is Unaffected by the Change of the Cox5 Isoform
in CIV. The purified III2-IV
5B
1 Δrox1 and III2-IV
5B
2 cox5ab SCs
were prepared for structural analysis by cryo-EM. Cryo-EM maps
(SI Appendix, Figs. S2 and S3 and Table S1) were obtained at 3.4-
Å resolution for Δrox1 and at 2.8-Å resolution for cox5ab and
revealed a CIII dimer flanked by either one or two copies of CIV
in the III2-IV
5B
1 or the III2-IV
5B
2 SC. Apart from the change in
CIII:CIV stoichiometry, the overall interaction of CIII and
CIV5B appeared to be very similar to that in the III-IV5A SCs
reported previously (19, 20).
As previously described for the III2-IV
5A
2 SC (19), the reso-
lution of CIV5B was lower than that of the CIII dimer, particu-
larly for those subunits at the periphery of the SC. Thus, for each
dataset, we followed the same procedure of using subtracted
experimental particle images and performing focused refinement
for each CIV5B and the CIII of the III2-IV
5B
1 Δrox1 SC (Mate-
rials and Methods). This approach effectively increased the reso-
lution of CIV5B and CIII to 3.4 Å and 3.3 Å, respectively, within
the III2-IV
5B
1 SC (SI Appendix, Figs. S2 and S4). For the cox5ab
III2-IV
5B
2 SCs, the resolution of each CIV
5B was increased to 2.8 Å
(CIV5B-a) and 3.0 Å (CIV5B-b); no additional refinement was
performed on CIII (SI Appendix, Figs. S3 and S4).
From the merged maps (Fig. 2) obtained for the III2-IV
5B
1
(Δrox1) and the III2-IV
5B
2 (cox5ab) SCs, all expected subunits
could be confidently modeled, namely 20 protein subunits for the
CIII dimer, including Qcr10, and 12 subunits in each CIV5B,
including Cox5B and Cox26 (19). An additional protein, Rcf2,
was unambiguously identified in the CIV5B of the III2-IV
5B
1 SC
structure (see below). All expected metal cofactors and pros-
thetic groups were well defined except for the calcium cation,
which was clearly present in the CIV5B of the III2-IV
5B
2 SC but
absent in that of the III2-IV
5B
1 SC (19, 34). A total of 30 lipids
were modeled in the III2-IV
5B
1 (41 in the III2-IV
5B
2) SC struc-
ture, including seven cardiolipins (eight in the III2-IV
5B
2 SC).
This compares to the 44 lipids in the previously reported
III2-IV
5A
2 SC structure, including eight cardiolipins. Among the
lost lipids in the III2-IV
5B
1 SC are a cardiolipin and a phosphocho-
line lost from the accessible side of CIII where no CIV is bound.
Alignment of the final models revealed little to no difference
in the CIII dimers between the III2-IV
5B
1 and III2-IV
5B
2 SCs, or
with the III2-IV
5A
2 SC previously published, with rmsd val-
ues <0.5 Å (with an average of 0.4 Å for the core domains and
values of 0.8 to 1 Å for the less-ordered Rip1 head domain and
Qcr10), highlighting the conserved assembly of CIII within all
III-IV SCs irrespective of protein stoichiometry. In addition, no
apparent differences were observed between the two CIII
monomers in the III2-IV
5B
1 SC structure. Specifically, the sub-
units of the CIII monomer that interact with CIV5B (Cor1, Cyt
c1, Rip1, and Qcr8) were virtually identical to the same subunits
in the CIII monomer that is free of these interactions. This
suggests that there are no conformational changes in CIII to
accommodate interactions with CIV. Similarly, alignment of the
three CIV5B monomers described here revealed only a few dif-
ferences, most of which were observed in CIV5B-b of the III2-
IV5B2 SC and most certainly arise from the lower quality of the
map in these regions. Finally, irrespective of the SC stoichiom-
etry, CIV5B displayed the bow-shaped conformation of Cox13
(19) that would preclude dimerization of the enzyme, as seen in
the bovine X-ray structure (35).
The interface between CIII and CIV also appeared to be well
conserved in the two CIV5B-containing SC structures. As in the
CIV5A-containing SC (19), Cox5B is the only CIV subunit
contributing to the III-IV interface with apparent interactions
on both sides of the IMM with multiple subunits of CIII and
with clear stabilizing contributions from lipids, including a
cardiolipin, in the membrane domain. In the matrix, Cox5B
adopts the same conformation as Cox5A (Fig. 3), with its N-
terminal domain also exhibiting the conformational shift seen
compared with the X-ray structure of the bovine ortholog (35,
36), which most certainly arises due to the conserved interac-
tions between Cox5 and Cor1 observed with both Cox5 iso-
forms (Fig. 3D).
Interactions within the IMM are also maintained, with a
conserved lysine (Lys94 in Cox5B, Lys97 in Cox5A) interacting
with Qcr8 via conserved bridging lipids (Fig. 3C). In the inner
membrane space (IMS), interactions with cytochrome c1 and
Fig. 1. The stoichiometry of the III-IV SC is governed by the level of CIV
biogenesis. (A) Reduced minus oxidized visible absorption spectra recorded
on mitochondrial membrane preparations from all three S. cerevisiae strains.
The absorption bands specific to cyt aa3 of CIV (445 and 604 nm), cyt b of CIII
(432 and 562 nm), and cyt c1 of CIII and cyt c (554 nm) are indicated with
arrows. Traces are normalized on their ΔA562–578 nm. (B) BN-PAGE gel of
solubilized mitochondrial membranes from all three S. cerevisiae strains. (C)
Reduced minus oxidized visible absorption spectra recorded on nickel-
affinity chromatography eluates from all three S. cerevisiae strains. Ab-
sorption bands are as in A. (D) BN-PAGE gel of the nickel-affinity chroma-
tography eluates obtained from those S. cerevisiae strains containing both
III2-IV2 and III2-IV1 SCs.
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Qcr6 are preserved despite differences in the two isoform se-
quences at their interface with Qcr6 (Fig. 3B). While the C-
terminal Lys153 in Cox5A forms an H-bond with Glu83 of Cyt
c1, the corresponding Lys151 in Cox5B is >6 Å apart. Instead,
the backbone carbonyl oxygen of Pro116 of Cox5B interacts with
the side chain of Lys45 of Qcr9 (Fig. 3A). These findings high-
light a conserved interaction of CIII and CIV in all S. cerevisiae
III-IV SCs.
Rcf2 Is Revealed in the III2-IV
5B
1 SC Structure. Strong additional
density was revealed in the CIV5B of the III2-IV
5B
1 SC away from
the interface with CIII, in a pocket formed by Cox1, Cox3,
Cox13, and Cox12. It could be modeled as a single polypeptide
chain, with both N and C termini in the IMS folded into two
transmembrane helices and an additional helix that extends in
the IMS, a pattern reminiscent of previous reports on respiratory
SC-associated factors Rcf1 and Rcf2 (25–28). This density was at
Fig. 2. Cryo-EM maps and fitted models of the III2-IV
5B
1 and III2-IV
5B
2 SCs. Membrane view (A) and IMS view (B) of the Δrox1 III2-IV
5B
1 and cox5ab III2-IV
5B
2
merged maps with overall dimensions of 224 × 165 × 114 Å and 289 × 165 × 114 Å, respectively. The transmembrane region is suggested by two dashed lines.
CIII is represented in blue and CIV in orange in both views. Rcf2 is highlighted in cyan.
Fig. 3. Protein–protein interactions between Cox5B and CIII. The atomic models of the CIV5B-containing SC purified from Δrox1 and the CIV5A-containing SC
purified from Δcox5b (PDB ID code 6HU9) were aligned on their Cox5 subunit. Around the main panel are zoom-in views of the interface between CIV
(orange) and CIII (blue) in the presence of Cox5A (gray) or Cox5B (green). Hydrogen bond and salt bridge interactions are shown as dashed lines. (A) Con-
formational changes at the C-terminal loop of Cox5B promote interactions with a phosphocholine (PCF) molecule and Qcr9 from CIII. (B) Electrostatic in-
teractions within the IMS between the C-terminal α-helix of Cox5B and Qcr6 of CIII. (C) IMM interactions between Cox5B and Rip1 via the conserved bridging
cardiolipin. (D) Interactions in the matrix between the N-terminal region of Cox5B and Cor1.
4 of 9 | www.pnas.org/cgi/doi/10.1073/pnas.1920612117 Hartley et al.
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a relatively low resolution, in the range of 7 to 10 Å, precluding
assignment. We thus collected a second dataset of the same
sample, and by increasing the number of aligned particles, we were
able to increase the local resolution in this region to 4 to 5 Å (SI
Appendix, Fig. S4A). This allowed us to confidently assign the new
density to the C-terminal fragment of Rcf2 (residues 107 to 205; SI
Appendix, Fig. S5), which comprises a short N-terminal α-helix
(residues 107 to 114), followed by a transmembrane helix-
hairpin-helix motif in the IMM (residues 118 to 175) and a fi-
nal C-terminal α-helix in the IMS (residues 182 to 203). This
assignment is further supported by a previous report showing
stable association of a C-terminal fragment of Rcf2 with CIV
after proteolytic processing of the full-length protein (28). In-
teractions of Rcf2 with multiple subunits of CIV were revealed
(Fig. 4A, cyan). Within the IMM, the HIG1 domain of Rcf2
forms extensive hydrophobic/Van der Waals interactions with
Cox3 and the transmembrane domain of Cox13 toward the
matrix (Fig. 4 C and D). The C-terminal α-helix of Rcf2 that
extends into the IMS makes core hydrophobic and flanked
electrostatic interactions with Cox12 (Fig. 4B), supporting a role
of Rcf2 in the recruitment/stabilization of Cox12 at a late stage
of CIV assembly (28).
Similar, although weaker, density was found on both CIVs in
the III2-IV
5B
2 SC map (SI Appendix, Fig. S6 B and C). The
density in both CIVs was sufficient to trace the main chain of a
protein with very similar topology as Rcf2. The local resolution
allowed side chain assignment to Rcf2 in CIV5B-a, but more data
are needed to definitively determine the additional density in
CIV5B-b. Nonetheless, these data suggest that Rcf2 is not spe-
cific to the III2-IV1 SC. In our previous study of the Cox5A-
containing SC (purified from the Δcox5b strain), mass spec-
trometry analysis detected the presence of Rcf1 and Rcf2 in the
final protein sample used for structure determination, even
though neither protein was detected in the final map (19). Re-
analysis of this dataset with focused refinement of both III2-
IV5A2 and III2-IV
5A
1 SCs (80% and 20% of particles, respec-
tively) using a mask that includes Rcf2 led to the observation of
additional density (SI Appendix, Fig. S6 D–F) where the trans-
membrane helices of Rcf2 were found in the Cox5B-
containing SCs.
Overall, our model of Rcf2 fits well in these extra densities,
but again, more data are needed to completely model and
identify the new protein within the Cox5A-containing SCs. The
resolution of this region of the map is stronger and better
Fig. 4. Rcf2 is revealed in the Δrox1 III2-IV
5B
1 SC structure. (A) Structure of CIV in the Δrox1 III2-IV
5B
1 SC with Rcf2 (cyan), Cox3 (dark gray), Cox12 (orange), and
Cox13 (purple) highlighted. (B) Interactions between the C-terminal helix of Rcf2 and Cox12 in the IMS. Residues that form interactions are labeled. (C)
Interactions within the IMM between Rcf2 and Cox13 and Cox3. (D) Interactions within the IMM between Rcf2 and Cox3. Residues of the conserved Q(R/Q)RQ
motif of Hig1 type 2 proteins are highlighted in red. (E) Sequence alignment of yeast Rcf2 (Uniprot: P53721), Rcf1 (Q03713), human Hig2a (Q9BW72), and
bovine Higd2a (Q05AT5). The numbers above the sequences correspond to the Rcf2 sequence. The alignment shows only the fraction of the determined Rcf2
structure, highlighting the HIG1 domain (residues 110 to 177) and the conserved Q(R/Q)RQ motif (stars underneath the sequences). The secondary structure
elements for Rcf2 are displayed above the sequence. The image was generated in ESPript (53).
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defined in the III2-IV1 SCs compared with the III2-IV2 SCs (SI
Appendix, Fig. S6), most likely resulting from an increased het-
erogeneity of CIV populations within the two halves of the III2-
IV2 SCs. While this could be explained by the presence of both
assembly intermediates and mature forms of CIV coexisting
within these SCs, or the presence of different hypoxia-induced
gene 1 (Hig1) type 2 proteins in each CIV monomer, the pos-
sibility that Rcf2 starts to dissociate after full maturation of the
III2-IV2 SCs cannot be excluded.
No Effect of Cox5 Isoform on CIV Activity. A twofold to threefold
increase in activity of CIV5B compared with CIV5A has been
reported in yeast (37) as well as in a mammalian system for the
equivalent COX4-2/1 isoform pair (38), in both cases suggesting
faster activity of the hypoxic isoform. An extensive steady-state
analysis of the oxygen reduction rates of yeast CIV isoforms
within mitochondrial membrane fragments, including compari-
son of TNs using horse heart cytochrome c or yeast iso-1 or iso-2
cytochrome c, has been published previously (23). Based on that
work, we measured the oxygen reduction rates of CIV in con-
ditions of maximum turnover, with horse heart cytochrome c,
N,N,N′,N′-tetramethyl-p-phenylenediamine (TMPD), and ascor-
bate for the three strains used in this study. In mitochondrial
membrane fragments, TNs were high at 1,022 ± 145 e.s−1 for
CIV5A and 1,006 ± 145 and 1,438 ± 94 e.s−1 for CIV5B in Δrox1
and cox5ab, respectively (Fig. 5A). This is consistent with the
previous characterization of the Δcox5b and cox5ab strains (both
with TNs at ∼1,400 e.s−1) but contrasts with the significant in-
crease in activity reported for Δrox1 (23). However, the accuracy
of TNmeasurements depends on the accurate quantitation of CIV
in the membrane preparations, which is difficult at the low levels
of CIV biogenesis seen in Δrox1 (Fig. 1A) and carries a greater
error than the difference of activity reported for the isoenzymes.
Accurate quantitation of CIV5B within Δrox1 can be achieved only
after metal affinity chromatography (Fig. 1C). TNs measured at
this stage of purification were very similar, at ∼250 e.s−1 in each
strain (Fig. 5A), again suggesting no difference in activity between
CIV5A and CIV5B. Of note, 70 to 80% of the CIV activity was lost
in this purification step, most likely due to delipidation of the
enzyme on the column, although we cannot exclude the possibility
that other types of interaction essential for full activity (involving
other proteins, for instance) could have been lost as well.
No Effect of CIV Isoform on Overall Pumping Activity. To assess
whether isoform exchange had an effect on CIII and CIV (or the
III-IV SC) proton translocation activity, we measured ADP/O
ratios from preparations of intact mitochondria from the Δcox5b
and cox5ab strains, which differ only in their unique expression
of CIV5A and CIV5B, respectively, using α-ketoglutarate as a
substrate. No difference was observed between the two variants
with ADP/O ratios measured at 1.93 ± 0.24 for Δcox5b and
2.06 ± 0.11 for cox5ab, giving H+/e stoichiometries of 3.4 ± 0.5
and 3.6 ± 0.3, respectively. These values are close to the theo-
retical value of 3 expected in yeast S. cerevisiae when six protons
are translocated for every two electrons from reduced ubiqui-
none passing through CIII and CIV to reduce 1/2 O2 to H2O.
This definitely shows that replacement of Cox5A with Cox5B, in
the absence of any additional change, has no effect on III-IV SC
pumping stoichiometry and overall energy conservation efficiency.
Discussion
Over the past 20 y, research efforts have intensified to understand
the role of mitochondrial respiratory SCs and, by association, the
function of several proteins that have been implicated in their
formation. To guide these investigations, several SC structures
have been solved at near-atomic resolution that revealed the
molecular details of the protein–protein interactions within the
SCs, although to date none has revealed any SC assembly factors.
In all mitochondrial CIV-containing SC structures available,
CIV interacts with CIII via subunits with expression isoforms. In S.
cerevisiae, in normoxic conditions of growth, the CIII-CIV in-
terface was shown to be made exclusively via Cox5A, the only
yeast CIV subunit that exists as two isoforms (Cox5A and Cox5B)
that are differentially expressed depending on oxygen levels. In
this study, we investigated the effect of CIV isoform exchange on
SC formation, structure, and activity using mutant strains designed
to selectively assemble CIV5B in normoxic conditions of growth,
albeit in very different amounts. We systematically compared our
results with those for a strain that assembles only CIV5A and
whose III2-IV
5A
2 SC structure was recently solved (19).
First, we showed that III-IV SCs form within the mitochondrial
membrane of all mutant strains irrespective of the Cox5 isoform,
even in Δrox1, where CIV is assembled only at very low levels.
However, in Δrox1, no III2-IV2 SCs could be detected, only III2-IV1
SCs. This is consistent with previous reports (2, 30), and it now
seems established that in yeast, III-IV SC stoichiometry is governed
by the relative amounts of CIII and CIV within the IMM.
Fig. 5. Isoform exchange has no effect on CIV oxygen reduction rates or SC pumping activity. (A) CIV oxygen reduction activity measured as TNs in conditions
of maximum turnover rate with horse heart cytochrome c, TMPD, and ascorbate in at least two independent preparations of mitochondrial membranes and
purified SCs after metal affinity chromatography from Δcox5b (n = 6 and 3), Δrox1 (n = 3 and 4), and cox5ab (n = 4 and 3). #Indicates where quantitation of
CIV within the sample bears an additionally large error due to its low abundance in the IMM. (B) Oxygen consumption rates of intact yeast mitochondria
respiring on α-ketoglutarate. ADP/O values were calculated from the average of the ADP/OT and ADP/ΔO values determined after ADP addition on prep-
arations of intact mitochondria from Δcox5b (n = 6) and cox5ab (n = 5).
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Next, we showed through cryo-EM that a change in Cox5
isoform had little effect on the overall structure of the III-IV SCs
formed, even though Cox5 was the sole CIV subunit to form the
III-IV interface. We measured similar O2 reduction rates and
proton translocation activities for all III-IV SCs, independent of
CIV isoform or SC stoichiometry. This calls into question the
purpose of isoform evolution in yeast, as in eukaryotes. It might
be found in, for instance, regulation of CIV assembly or activity
in hypoxia, perhaps involving posttranslational modifications or
allosteric effectors such as ATP (39). Further studies on yeast
strains grown in low oxygen concentrations might be needed to
reveal the effect of CIV isoforms in yeast.
Unexpectedly, the structures described above revealed a Hig1
type 2 protein associated with a respiratory SC. We could con-
fidently detect the C-terminal fragment of Rcf2 within both
CIV5B-containing SCs and have found evidence if not of its
presence, then of a protein with very similar transmembrane
topology in the CIV5A-containing SCs.
The Hig1 protein family was originally described as being strongly
inducible by hypoxia in an HIF-1–dependent manner (40). Today,
members of this family are defined by their HIG1 domain, a specific
sequence pattern within two transmembrane helices and a loop.
The family is further subdivided into two classes. The Hig1 type 1
proteins (HIG1A in mammals) are specific to higher eukaryotes,
and the Hig1 type 2 proteins (Rcf1 and Rcf2 in yeast and HIG2A in
mammals), characterized by their QX3(R/Q)XRX3Q motif, are
found in all eukaryotes and α-proteobacteria. Hig1 type 2 proteins
have been identified as essential components of the mitochondrial
III-IV SCs in both yeast and mammals (25–27), with some specu-
lation that they could form the interface between CIII and CIV.
However, as neither Rcf1 nor Rcf2 were resolved in the first III-IV
SC structures obtained in yeast (19, 20), it became clear that they
are not essential for SC stability.
Evidence is mounting for a role of Hig1 proteins in supporting
CIV assembly and activity (25, 26, 28–30, 41–43). It has been
proposed that Hig1 type 1 proteins (specific to higher eukary-
otes) are involved in the initial step of CIV assembly (42), and
that Hig1 type 2 proteins (yeast Rcf1, Rcf2 and mammalian
HIG2A) are involved in the later stages, for the assembly of
subunits Cox13 and Cox12 in yeast. Specifically, Rcf1 has been
implicated in the recruitment of Cox13 and possibly Rcf2 (26),
but evidence suggests that it leaves CIV after stable assembly of
Cox13 (29), consistent with a role of Rcf1 as an assembly factor.
The position of the C-terminal fragment of Rcf2, as revealed in
this work, is consistent with a role in the assembly of Cox12;
however, its stable occurrence within the Cox5B-containing SC
structures presented here strongly suggests that it remains as-
sociated to CIV within the III-IV SCs and serves as a stoichio-
metric subunit of CIV. More data are needed to definitively
establish whether Rcf2 or another Rcf protein is present in both
CIV5Bs of the III2-IV
5B
2 or the Cox5A-containing SCs.
Several studies of Rcf1 and/or Rcf2 gene knockout mutant
strains have highlighted the importance of these proteins for
optimal yeast CIV assembly and activity. The mutant Δrcf1, but
not Δrcf2, resulted in a 50% decrease of CIV levels and reduced
CIV TNs were observed in both mutant strains (30, 41). In ad-
dition, Rcf2 has extensive interactions with Cox13, Cox3, and
Cox12, all of which contribute to the binding site of cytochrome
c. Disruption or destabilization of this region of CIV in Δrcf1
and/or Δrcf2 strains would explain their reportedly increased
reactive oxygen species production (26, 27).
Importantly, the residues of CIV described herein to interact
with the HIG1 domain of Rcf2 are conserved in mammalian
orthologs, suggesting that similar interactions could occur in
mammalian systems. Mammalian Hig1 proteins are shorter, and
sequence alignments suggest that they lack the C-terminal IMS
helix of Rcf2 that interacts with Cox12 (Fig. 4E). Stabilization of
this region could instead be provided by NDUFA4, as seen in the
structure of CIV within the human respirasome (18). It is also
noteworthy that as for NDUFA4 of CIV within the mammalian
respirasome, a Hig1 type 2 protein at the position of Rcf2 would
hinder CIV dimerization, as seen in the bovine X-ray structure
(35). Whether Hig1 type 2 proteins are specific components of
those CIVs that form only III-IV SCs remains to be investigated.
To date, no evidence of Hig1 proteins or of NDUFA4 has been
reported in structural studies of isolated mammalian CIV (35, 36),
and knockdown of HIG2A in mammalian cells has been shown to
cause depletion of all higher-order SCs that contain CIV (27).
Although our understanding of the organization of respiratory
proteins within the dense environment of the IMM is rapidly
advancing, continued efforts involving structural biology, genetic,
proteomic, and functional studies will be needed to elucidate the
role of SC formation.
Materials and Methods
Yeast Strain and Cell Growth. Three strains of S. cerevisiae were used in this
study, all constructed from W303-1B (Mat α ade2 leu2 trp1 ura3) (23, 31) and
containing a 6-histidine tag at the C terminus of Cox13: a Δcox5a Δrox1 strain
that expresses only Cox5B (rox1::KanMx4 cox5a::URA3), a cox5ab strain that
expresses Cox5B under control of the Cox5A promoter (cox5a::COX5B), and
a Δcox5b strain that expresses only Cox5A (cox5B::KanMx4). Yeast cells
were grown aerobically at 28 °C in YPGal medium and harvested in late log
phase by centrifugation as described by Meunier et al. (31). Cells were
washed once in a resuspension/centrifugation cycle in 50 mM KPi (pH 7.0)
and stored at −80 °C until use.
Preparation of Mitochondrial Membranes and SC Purification. The thawed cells
were disrupted by mechanical means using glass beads (425 to 600 μm
diameter) and a bead-beater in a medium composed of 50 mM KPi, 650 mM
D-mannitol, 5 mM EDTA, and 0.1 mM PMSF, pH 7.4 (31). Cell debris was
removed by centrifugation at 5,600 × g for 20 min at 4 °C, and the mito-
chondrial membranes were subsequently pelleted by centrifugation at
120,000 × g for 50 min at 4 °C. They were washed once by a resuspension/
centrifugation cycle in 50 mM KPi, 100 mM KCl, 10 mMMgCl2, 150 μM CaCl2,
and 0.1 mM PMSF, pH 7.4, and twice in 50 mM KPi, 2 mM EDTA, and 0.1 mM
PMSF, pH 7.4, as described previously (19), then stored at −80 °C in a minimal
volume of 50 mM Hepes, pH 8.0. Respiratory SCs were purified after mem-
brane solubilization with 1% GDN (Anatrace) by affinity chromatography
(HisTrap HP column, 5 mL; GE Healthcare) and gel filtration (Superose 6
Increase column; GE Healthcare), using an Äkta Pure 25 chromatography
system (GE Healthcare) operated at 4 °C, as described previously (19). In
brief, for affinity chromatography, the column was equilibrated with 50 mM
Hepes, 500 mM NaCl, 5 mM imidazole, and 0.05% GDN, pH 8.0, followed by
overnight loading of the solubilized proteins. The column was then washed
with the same buffer, and the SCs were subsequently eluted with 50 mM
Hepes, 150 mM NaCl, 0.05% GDN, and 100 mM imidazole, pH 7.2. The same
buffer but without imidazole was used for gel filtration. When required,
samples were concentrated using 100-kDa MWCO centrifugal concentrators
(GE Healthcare).
Analytical Methods. The amounts of CIII and CIV within protein samples were
determined from their sodium dithionite reduced minus oxidized difference
absorption spectra recorded in 50 mM Hepes and 0.1% undecylmaltoside, pH
8.0, in the visible range, using extinction coefficients (ΔƐ) of 28 mM−1 cm−1
(ΔA562–578 nm) and 26 mM−1 cm−1 (ΔA604–621 nm) for CIII and CIV, respectively
(19). Precast NativePAGE 3 to 12% Bis-Tris gels (Invitrogen) were used in
accordance with the manufacturer’s instructions for BN-PAGE analysis, as
described previously (19).
Activity Measurements. Steady-state oxygen consumption rates were mea-
sured at 25 °C using a Clark-type oxygen electrode (Oxygraph; Hansatech) in
a medium of 10 mM KPi and 50 mM KCl, pH 6.6, supplemented with 0.05%
GDN and 50 μM equine heart cytochrome c as described previously (19). SC
activity was measured in the presence of 500 units/mL SOD and 250 units/mL
catalase; a baseline was recorded before initiation of the reaction by the addition
of 40 μM decylubiquinol. CIV activity was measured in the presence of 40 μM
TMPD; a baseline was recorded before initiation of the reaction by the addition of
2 mM Na+-ascorbate. TNs were calculated from linear fitting of the oxygen
consumption rate with Origin (OriginLab) using the formula TN (e.s−1) = O2
consumption gradient (M.s−1) × 4/[CIII or CIV] (M) for SCs or CIV, respectively. The
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data presented are the average of several measurements performed on different
SC preparations. Error bars were calculated from the SD from the mean.
Cryo-EM. Grids for cryo-EM (UltrAuFoil R1.2/1.3; Quantifoil) were prepared
using a Vitrobot Mark IV (Thermo Fisher Scientific) after 1:1 or 1:3 dilution of
purified Δrox1 III2-IV
5B
1 SC (2.9 μM CIII; 0.6 μM CIV) or cox5ab III2-IV5B2 SC
(6.9 μM CIII; 2.9 μM CIV) in 50 mM Hepes, 150 mM NaCl, and 0.05% GDN, pH
7.2 (12- to 14-s blotting time, 4 °C, and 100% humidity), as described pre-
viously (19). Data were collected with a Titan Krios microscope (Thermo
Fisher Scientific) operated at 300 kV and equipped with a Quantum energy
filter (Gatan), using EPU software (Thermo Fisher Scientific).
Two datasets were recorded for the Δrox1 III2-IV
5B
1 SC, one at the Electron
Bio-Imaging Centre (eBIC; Diamond Light Source, Oxfordshire, UK) and one
at Birkbeck College, in otherwise similar conditions so that the particles from
the two datasets could be merged (see below). A post-GIF K2 Summit direct
electron detector (Gatan), operating in counting mode at a nominal mag-
nification of 130,000× (pixel size of 1.048 Å), was used for image collection,
and an energy slit with a width of 20 eV was used during data collection. A
total of 4,140 micrographs were collected at eBIC (dose rate of 5.14 e/Å2/s on
the specimen and a total dose of 56.4 e/Å2 fractionated over 40 frames;
nominal defocus range set from −1.6 μm to −3.6 μm) and 2,981 micrographs
were collected at Birkbeck College (dose rate of 5.14 e/Å2/s on the specimen
and a total dose of 51.4 e/Å2 fractionated over 40 frames; nominal defocus
range set from −1.5 μm to −2.7 μm).
The cox5ab III2-IV
5B
2 SC data were collected at eBIC in “superresolution”
mode using a post-GIF K3 Summit direct electron detector (Gatan) operating
in counting mode at a nominal magnification of 81,000× (pixel size of 1.085
Å). An energy slit with a width of 20 eV was used during data collection. A
total of 3,634 micrographs were collected with a dose rate of 22.4 e/pixel/s
on the specimen and a total dose of 56.4 e/Å2 fractionated over 40 frames
and a nominal defocus range set from −1.5 μm to −2.8 μm.
Image Processing. The two Δrox1 III2-IV
5B
1 SC datasets were processed sep-
arately until particles were picked. In both cases, MOTIONCOR2 (44) was
used for frame alignment and exposure weighting, while CTFFIND4.1 (45)
was used to estimate the contrast transfer function (CTF) parameters. Micro-
graphs with excessive specimen drift, overfocus, or ice defects were removed
manually. Reference-free particle picking was performed with Gautomatch
v0.53 (written by Kai Zhang; https://www.mrc-lmb.cam.ac.uk/kzhang/
Gautomatch/), using a 384-Å2 box size. This resulted in the selection of
44,268 particles from 3,648 micrographs in the first dataset and 44,968
particles from 2,541 micrographs in the second dataset. Particles were
combined, resulting in a final particle number of 89,236, and 3D classifica-
tion was performed in Relion (46) using a map generated from homoge-
neous refinement of the first dataset in cryoSPARC2 (47). This revealed a
3.41-Å resolution map, based on the Fourier shell correlation (FSC) gold
standard. To improve resolution of the SC, we used a particle subtraction
approach, as described previously (19). In brief, a mask was generated
around CIII (or CIV) and used to subtract density from the particles, resulting
in a new set of particles that was used in focused refinement to improve
local resolution on both complexes (SI Appendix, Figs. S2 and S4 A and C).
For real-space refinement, the two maps (CIV5B at 3.41 Å and CIII at 3.29 Å)
were merged using UCSF Chimera (48).
Frame alignment and CTF estimation of the cox5ab III2-IV
5B
2 SC dataset
were performed using MOTIONCOR2 in Relion and CTFFIND4.1 within the
cryoSPARC v2 interface, respectively. The superresolution micrographs were
binned 2 × 2 (1.085 Å/pixel) during frame alignment. An initial set of 892
particles was picked manually and then classified into 50 representative 2D
classes, 12 of which were then used as templates for automatic particle
picking in cryoSPARC v2. Autopicked particles (138,154) were then classified
using multiple iterations of reference-free 2D classification, and an initial
model was built using ab initio reconstruction from 65,999 particles. No III2-
IV1 SCs were revealed within the final particles, so homogeneous refinement
was used to increase the resolution of the map to 2.8 Å based on the FSC
gold standard. As in the Δrox1 III2-IV
5B
1 SC, the cox5ab III2-IV
5B
2 map dis-
played high resolution at the core of CIII (up to 2.5 Å; SI Appendix, Fig. S4B),
but lower resolution toward the periphery of the CIV monomers. To increase
the resolution of the CIV monomers, particle subtraction was used to remove
density for the CIII core dimer and one monomer of CIV, and then local
refinement was used with a mask generated around the CIV monomer of
interest. This resulted in three maps, one for the core of the SC (covering CIII
and part of the two CIV monomers as well) and one each for the two
monomers of CIV (CIV5B-a and CIV5B-b), with resolutions of 2.80, 2.83, and
3.01 Å, respectively (SI Appendix, Figs. S3 and S4 B and D). For real-space
refinement, the maps were then merged using UCSF Chimera.
For the CIV5A within the Δcox5b III2-IV
5A
1 and III2-IV
5A
2 SCs, data collec-
tion, frame alignment, and CTF estimation of micrographs have been
reported previously (19). For the present work, the micrographs were fur-
ther processed in cryoSPARC v2. A total of 98,968 particles were picked, of
which 57,132 were selected from the 2D classification for ab initio recon-
struction, including particles of both III2-IV2 and III2-IV1 SCs. The generated
ab initio models together with their particles (44,195 for the III2-IV2 SC and
12,937 for the III2-IV1 SC) were further used for nonuniform refinement. To
generate focused refined maps on the CIVs, we followed the same proce-
dure as above for signal subtraction, followed by refinement with a CIV
mask that included Rcf2. The resulting maps obtained for CIV5A within the
III2-IV1 SC (4.1 Å) and for CIV
5A-a and CIV5A-b within the III2-IV2 SC (3.09 and
3.24 Å, respectively) are shown in SI Appendix, Fig. S6 E and F.
Model Building. The two individual maps after focused refinement corre-
sponding to CIII and CIV in the Δrox1 III2IV
5B
1 SC were aligned on the initial
map and merged in Chimera using the “vop maximum” command. The di-
meric CIII and one monomer of CIV from the previously determined yeast
III2IV
5A
2 SC (PDB ID code 6HU9) (19) were fitted into this merged map using
Chimera, and this model was further improved through several iterations of
model building in Coot (49) and real-space refinement in Phenix (50). The
map was of sufficient quality to fit all expected prosthetic groups, including
heme groups and metal clusters, and enabled the assignment of amino acids
in all chains, including Rcf2. Some regions displayed characteristic dis-
order, such as the C terminus of Rip1 (although its Fe-S cluster was clearly
visible), and the N terminus of Qcr6 (1 to 72) was not resolved, a feature
common to previously determined crystal structures of CIII. Additional
densities resembling long carbon chains were modeled as palmitoyl-
phosphatidylethanolamine (PEF), diacyl-glycero-phosphocholine (PCF), and
cardiolipin based on similarities to previously published structures in which
these ligands were observed. For the refine space refinement in Phenix, we
used secondary structure restraints as well as Ramachandran and rotamer
restraints. Geometry definitions for the ligands were defined from values in
the CCP4 ligand library (51). Additional bond and distance restraints were
implemented on specific molecules based on previously published high-
resolution structures. No symmetry restraints were applied during real-
space refinement. The model was then checked in Coot for any re-
finement errors and manually corrected. The final Δrox1 III2IV
5B
1 SC model
contains 6,002 protein residues, eight heme groups (four B-type hemes in
the two cytochrome b subunits of CIII, two C-type hemes in the two cyto-
chrome c1 subunits of CIII, and one heme a and one heme a3 in Cox1 of CIV),
two Fe-S clusters (one in each Rip1 subunit of CIII), and four noniron metal
centers (CuB and a magnesium in Cox1, the dinuclear CuA in Cox2, and a zinc in
Cox4). In addition, we modeled seven cardiolipin, 18 PEF, and six PCF molecules.
The same procedure was used to build the CIII dimer and the two CIV
monomers of the cox5ab III2-IV2 SC in Coot individually, using the three
refined maps described above. The models of the proteins in the cox5ab III2-
IV2 SC share many features with the models that form the Δrox1 III2IV
5B
1 SC,
namely the heme groups, metal centers, and number of chains present in
each protein (including Rcf2 in each CIV monomer). The same regions of
Rip1 and Qcr6 in CIII displayed increased disorder and reduced resolution.
Additional densities for lipids were also observed, many in conserved posi-
tions. All three models were refined individually using the real-space refine
tool in Phenix as described above. The models were then checked manually
for errors before a final real-space refinement on the combined cox5ab III2-IV2
SC using the merged map. The final cox5ab III2-IV2 SC model contains 7,902
protein residues, 10 heme groups (the same distribution of hemes as above
but with one additional heme a and one heme a3 in the second CIV monomer),
two Fe-S clusters (one in each Rip1 subunit of CIII), and 10 noniron metal
centers (CuB, a magnesium and a calcium in Cox1, the dinuclear CuA in Cox2,
and a zinc in Cox4, duplicated in the second CIV monomer). There was also an
increase in the number of lipids present; eight cardiolipin, 26 PEF, and seven
PCF molecules were modeled into the cox5ab III2-IV2 SC.
Refinement and model statistics are summarized in SI Appendix, Table S1.
Maps and molecule representations in all figures were prepared using
PyMOL and UCSF Chimera.
Intact Mitochondria Preparation and ADP/O Ratio Measurements. Intact mi-
tochondria were prepared from 12 to 15 g of yeast cells (wet weight) grown
aerobically at 28 °C in YPGal medium (yeast extract 1%, peptone 2%, ga-
lactose 2%) and harvested in log phase. Digestion of the yeast cell wall was
performed enzymatically following the protocol of Guérin et al. (52). ADP/O
measurements were performed with the oxygen-electrode setup described
above in a medium of 0.65 M mannitol, 5 mM MgCl2, 3 mM KPi, 10 mM Tris-
maleate, 17 mM KCl and 0.1% BSA (w:v) at pH 7.0 and 25 °C. Oxygen
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consumption rates were determined after successive additions of intact
mitochondria (10 to 20 μL), 10 mM α-ketoglutarate (Na+ salt), and 100 μM
ADP (Na+ salt). The latter induced state 3 of respiration, which spontane-
ously reverted to state 4 after all the ADP was transformed into ATP. Re-
spiratory rate ratios, calculated from the ratio of the state 3 over state 4
oxygen consumption rates measured, ranged from 1.4 to 2.0, depending on
preparations. The ADP/O values presented here are the average of the ADP/
OT and ADP/ΔO values determined after ADP addition. Error bars are cal-
culated from the SD from the mean.
Data Availability. All relevant data are included in the paper and/or are
available from the corresponding author on reasonable request. Cryo-EM
maps have been deposited in the Electron Microscopy Data Bank under
accession nos. EMD-10317 (CIII2) and EMD-10318 (CIV
5B) for Δrox1; EMD-
10340 (III2IV
5B
2 SC), EMD-10335 (CIV
5B-a), and EMD-10334 (CIV5B-b) for
cox5ab; and EMD-10375 (CIV5A-a) and EMD-10376 (CIV5A-b) for Δcox5b. The
coordinates of the atomic models of the CIV5B-containing SCs built from a
combination of EM maps have been deposited in the Protein Data Bank
under ID codes PDB ID 6T15 (Δrox1 III2IV
5B
1) and 6T0B (cox5ab III2IV
5B
2).
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